C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions White Paper C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions Replace TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA. Learn more…Certara2025 年 10 月 3 日
Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…Certara2025 年 10 月 2 日
37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Conference 37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Certara2025 年 9 月 22 日
Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings Webinar Certara 大学:Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings Danielle Pillsbury2025 年 9 月 22 日
Best Practices in Clinical Pharmacology Gap Analysis Blog 临床药理学差距分析最佳实践 2025 年 9 月 19 日 Submitting your New Drug Application (NDA) to the FDA is the ultimate…Certara2025 年 9 月 19 日
The Top 10 Things You Need to Know About ADNCA Datasets Guide The Top 10 Things You Need to Know About ADNCA Datasets Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…Certara2025 年 9 月 11 日
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Certara2025 年 9 月 4 日
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) Webinar 设计高价值药物研发计划:From Concept to First-in-Human (FIH) Danielle Pillsbury2025 年 8 月 29 日
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…Certara2025 年 8 月 13 日